Scientific Program
(preliminary, as of March 2023)
Wednesday, May 31, 2023
17h00 – 18h00
General Assembly E-ISFA
Thursday, June 1, 2023
08h30 – 08h55
Opening Ceremony
Chairs: B. Hohenstein, ISFA President (DE), W. Ramlow, E-ISFA President (DE)
09h00 – 10h20
Apheresis around the world I:
Country specific aspects
Kurt Derfler (Institute ATHOS, Vienna, AT)
Kahlid Al Rasadi (Sultan Qaboos University, Biochemistry, OM)
Organization and national activities of therapeutic apheresis in Oman
Ken Yamaji (Department of Internal Medicine and Rheumatology, Juntendo University, Tokyo, JP)
Amber Sanchez (University of California San Diego, US)
Organization and national activities of therapeutic apheresis in the USA
Lipid disorders and CVD I:
Lipid disorders – it all starts with the measurement
Winfried März (SYNLAB Akademie, DE)
Dyslipidemia – it all starts with a correct measurement
Johanna Schachtl-Riess (Medical University of Innsbruck, AT)
Lipoprotein(a) – from genetics to phenotype
Jeffrey Kroon (University of Amsterdam, NL)
Evidence for a strong pro-inflammatory potential of lipoprotein(a)
Patrick Moriarty (University of Kansas Medical Center, Kansas City, US)
Lipoprotein-apheresis and its effect on HDL functionality
10h20 – 10h45
Coffee Break, Exhibition & Poster Viewing
10h45 – 12h05
Apheresis around the world II:
South East Asian perspectives
Sasitorn Siritho (Bumrungrad International Hospital, TH)
Systematic review of TPE practices in central neuroimmunological disorders: evolving concepts in South East Asia
Lu Fiong Hiew (Kuala Lumpur Hospital, MY)
Uniting the world through TPE: SEATPEC challenges & potential future collaborations
Nghia Hoang (Military Hospital, Ho Chi Minh, VN)
TPE and its challenges in Vietnam
Dhayalen Krishnan (Kuala Lumpur General Hospital, MY)
Introduction to SEATPEC, best practices and TPE guidelines in South East Asia
Registries
Registries as research tools in apheresis
Christian Schumann (MVZ Kempten, DE)
CACOV – an apheresis registry for severely ill acute COVID patients
Bernd Hohenstein (Nephrologisches Zentrum Villingen-Schwenningen, DE)
The German Long-Covid Apheresis Register – design and first experiences
Wanja Bernhardt (Centre for Hypertension, Kidney and Metabolic diseases, Hanover, DE)
The German Lipoprotein Apheresis Register – a specific analysis of Lp(a) apheresis patients
Kahlid Al Rasadi (Sultan Qaboos University, Biochemistry, OM)
The Gulf region FH registry
12h05 – 12h30
Break and Poster Viewing
12h30 – 13h45
Lunch Symposium –
Miltenyi Biotec
Lunch Symposium –
Daiichi Sankyo
13h45 – 14h00
Break and Poster Viewing
14h00 – 15h15
Apheresis around the world III:
Current updates & issues (from the American Society for Apheresis – ASFA)
Joseph (Yossi) Schwartz (Ichan School of Medicine at Mount Sinai, New York, US)
Growing variations in collections for further manufacturing
Betty Doggett (Carter BloodCare, Laird Hill, US)
Vascular access – issues & resolutions
Nicole Aqui (Perelman School of Medicine, University of Pennsylvania, US)
ASFA Guidelines for Therapeutic Apheresis
Autoimmune diseases I
Neuroimmune diseases and immunomodulation
Wolfgang Köhler (Leipzig University, DE)
The role of apheresis therapy in MS and NMOSD
Olivier Moranne (CHU Caremeau Nimes, University Montpellier, FR)
Immunomodulatory effect associated with therapeutic plasmapheresis
N. N.
Begrüßung
Jens Ringel (DE)
Apherese, eine erfolgreiche Geschichte
Apherese ist nicht gleich Apherese
Ultima ratio bei Lipoproteinstörungen
15h15 – 15h30
Coffee Break & Poster Viewing
15h30 – 17h30
Apheresis around the world IV
Apheresis therapy in Japan
tba.
Apheresis in critical care medicine
Jan Stange (University Medical Center Rostock, DE)
Recent developments in the field of extracorporeal albumin detoxification (ECAD) for liver support
Gerd Klinkmann (University Medical Center Rostock, Department of Anesthesiology and Intensive Care Medicine, DE)
Extracorporeal immune cell therapy in sepsis
Steffen Mitzner (University Medical Center Rostock, DE)
Cytokine adsorption in sepsis and septic shock – still under debate
Amber Sanchez (University of California San Diego, US)
How to combine multiple extracorporeal systems in critical care
Sascha David (Zurich University Hospital, CH)
TPE in septic shock: to remove and replace
Apherese mehr als nur Lipidreduktion
Heparin oder Citrat zur Antikoagulation
Pflegerische Aspekte in der Apheresebehandlung von
Long/Post-Covid Patienten
Pflegerische Aspekte in der Apheresebehandlung von Kindern
17h30 – 19h30
Welcome Reception & Poster Session
Friday, June 2, 2023
08h30 – 09h50
Apheresis around the world V:
Country specific aspects
Shamanna Iyengar (Manipal Academy of Higher Education, IN)
On the way to establish a lipid apheresis program in India by Lipid Association of India (LAI)
Ahmed Alsaraff (KW)
LDL apheresis in homozygous familial hypercholesterolemia in Kuwait
Luigi Vernaglione (Perrino Hospital, Brindisi, IT)
Cross sectional analysis of apheretical therapies in Italy
Olivier Moranne (CHU Caremeau Nimes, University Montpellier, FR)
Organization and national activities of therapeutic apheresis in France
Guest workshop:
Association of German Dialysis Centers (DN e. V.)
Georg Schlieper (Dialysis Centre Hanover, DE)
Is there a role for immunoadsorption in Post Covid?
Volker Schettler (Center of Nephrology, Dialysis and Apheresis, Göttingen, DE)
The German Lipoprotein Apheresis Registry (GLAR) – Summary of the tenth annual report
Jan Kielstein (Braunschweig Hospital, DE)
From sepsis to COVID – apheresis therapy in critical care medicine
09h00 – 12h00
Apherese-Weiterbildung in deutscher Sprache: Anwenderworkshop Teil 1
tba.
09h50 – 10h20
Coffee Break, Exhibition & Poster Viewing
10h20 – 12h10
COVID-19 I:
Apheresis in COVID-19 and its complications
Carmen Scheibenbogen (Charité – Universitätsmedizin Berlin, DE)
Long-term consequences of COVID and current therapeutic perspectives
Beate Jäger (DE)
Long COVID – why apheresis therapy could make the difference
Harald Matthes (Havelhöhe Community Hospital, Berlin, DE)
Is apheresis therapy an option for neuroinflammatory Post-vaccination syndrome?
Panel discussion – pro and contra
Lipid disorders and CVD II:
Apheresis targeting microcirculation and inflammation
Luigi Vernaglione (Perrino Hospital, Brindisi, IT)
Apheresis to improve rheology – indications and results
Dusit Lumlertgul (Faculty of Medicine, Chiang Mai, TH)
Double filtration plasmapheresis (DFPP) to improve microcirculation
Jan Torzewski (Allgäu Hospital Network, Immenstadt, DE)
CRP – from laboratory parameter to key player of inflammation
Shuzo Kobayashi (Shonan Kamakura General Hospital, JP)
A new adsorber for the treatment of critical limb ischemia
Rosita Bihariesingh et al. (Academic Hospital Paramaribo Suriname)
First-in-Man: Plasmapheresis with a novel blood separation device in hypertriglyceridemia and acute pancreatitis
12h10 – 12h30
Lunch Break, Exhibition & Poster Viewing
12h30 – 13h45
Lunch Symposium – Fresenius Medical Care
Lunch Symposium
13h45 – 14h00
Lunch Break, Exhibition & Poster Viewing
14h00 – 15h20
COVID-19 II:
Treatment approaches in COVID and its consequences
Wladimir M. Szpirt (Rigshospitalet, Copenhagen, DK)
Plasma exchange utilizing convalescent plasma in severe COVID patients
Sebastian Koball (University Medical Center Rostock, DE)
How to evaluate apheresis efficacy in patients suffering from Long COVID?
Gunnar Bücker (Nephrology group practice, Osnabrück, DE)
HELP apheresis in Long COVID – a practice report
Julia Weinmann-Menke (Universitätsmedizin Mainz, DE)
New guidelines and developments:
Technical developments and recommendations
Uwe H. Wallstab (mdXperts GmbH, Cologne, DE)
Relevance of sufficient clinical safety and performance data to maintain CE mark of apheresis devices
Viktoria Weber (Danube University Krems, AT)
Influence of the column surface on therapeutic apheresis – an old issue but new developments are rising
Volker Witt (Paediatric Hospital “St. Anna”, Vienna, AT)
ASFA Guidelines in therapeutic apheresis – the new issue 2023
Kensuke Owari et al. ( TAGCyx Biotechnologies, Inc., Tokyo, Japan)
Development of next generation apheresis using artificial base DNA Aptamer
Lipid disorders and CVD III: Workshop German Lipid League
Oliver Weingärtner (University Hospital Jena, DE)
A nationwide initiative to reach lipid targets
Anja Vogt (Ludwig Maximilians University Hospital, Munich, DE)
Novel lipid lowerting medications – current status and future perspectives
Ulrich Julius (University Hospital Dresden, DE)
DIAMOND study – a comparison between plasma and whole blood lipoprotein apheresis
13h00 – 15h30
Apherese-Weiterbildung in deutscher Sprache: Anwenderworkshop Teil 2
tba.
15h20 – 15h45
Coffee Break, Exhibition & Poster Viewing
15h45 – 17h30
Lipid disorders and CVD IV:
Treatment modalities in clinial practice
Wanja Bernhardt (Dialysis Centre Hanover, DE)
Long-term experience of Lp(a) apheresis in outpatient care
Tiziana Sampietro (National Research Council Institute of Clinical Physiology, Pisa, IT)
The role of lipoprotein apheresis on hypercholesterolemia and L(pa) – the Pisa experience
Ulrich Julius (University Hospital Dresden, DE)
Cardiovascular events before and during apheresis treatment – a detailed analysis for vascular regions
Jannecke Mulder (NL)
Quality of life in Dutch hoFH patients
Mariko Harada-Shiba (National Cerebral and Cardiovascular Center, Osaka, JP)
Development of novel drug for primary chylomicronemia by using antisense
Autoimmune diseases II:
Apheresis in rheumatologic and inflammatory bowel disease
Andreas Kronbichler (Medical University Innsbruck, AT)
Apheresis therapy in autoimmune vasculitides – PEXIVAS is not the end
Yoshihiro Endo (Shiga University of Medical Science, Otsu, JP)
Novel hemo-adsorbent for ulcerative colitis in Japan
Makoto Naganuma (Keio University School of Medicine, Tokyo, JP)
Recent trends of apheresis treatment for inflammatory bowel disease
Ken Yamaji (Juntendo University, Tokyo, JP)
Is apheresis therapy still an option in rheumatic diseases?
Andreas Goebel (University of Liverpool, UK)
Introducing a study design to evaluate immunoadsorption in fibromyalgia
Apherese-Weiterbildung
in deutscher Sprache: Workshop Vaskulärer Zugang
tba.
18h30 – 23h00
Congress Dinner
Saturday, June 3, 2023
08h30 – 10h15
Autoimmune diseases III
Apheresis for renal diseases
Lionel Rostaing (CHU Grenoble Alpes, Grenoble, FR)
Apheresis and desensitization before kidney transplantation
Benjamin Savenkoff (CHR Metz-Thionville, FR)
The role of apheresis therapy in glomerulopathies
Vladimir Kuklin (NO)
Title tba.
Wladimir Szpirt (Rigshospitalet, Copenhagen, DK)
An evolution in treatment of anti GBM nephritis – plasma exchange or imlifidase?
Lipids and CVD V:
Pleiotropic and other expected windfall gains
Grit Waitz (BioArtProducts, Rostock, DE)
Cardiometabolic risk assessment – the impact of comorbidities
Mariko Harada-Shiba (National Cerebral and Cardiovascular Center, Osaka, JP)
Lipoprotein apheresis for the treatment of familial hypercholesterolemia in Japan
Takafumi Ito (JP)
Efficacy and safety of LDL apheresis for the treatment of cholesterol crystal embolism
N. N.
10h15 – 10h45
Coffee Break, Exhibition & Poster Viewing
10h45 – 12h30
Future perspectives of apheresis therapy
The future perspectives of apheresis
Patrick Moriarty (University of Kansas Medical Center, Kansas City, US)
Future perspectives in apheresis therapy – lipoprotein apheresis
Jan Kielstein (Braunschweig Hospital, DE)
Title tba.
Lionel Rostaing (CHU Grenoble Alpes, Grenoble, FR)
Future perspectives in apheresis therapy – renal diseases and transplantation
Reinhard Klingel (Apheresis Research Institute, Cologne, DE)
Future perspectives in apheresis therapy – immune-mediated conditions
Pediatric apheresis
Apheresis in children and adolescent patients
Marc Fila (CHU Montpellier, FR)
Efficacy and tolerance of PLEX/IA in peadiatric neurology: results of a nationwide study in France
Wolfgang Ries (Diako Hospital Flensburg, DE)
Severe chronic fatigue syndrome (ME/CFS) in children – when is immunoadsorption justified?
Julia Thumfart (Charité – Universitätsmedizin Berlin, DE)
Apheresis therapy for pediatric neurological diseases – a German perspective
Volker Witt (Paediatric Hospital “St. Anna”, Vienna, AT)
Title tba.
12h30 – 13h00
Closing Ceremony & Awards Presentation
13h00
Farewell